SF ... nice summary of my thoughts as well, only said better.

I always believed in the science, and "thought" this was going somewhere. Now, I more strongly believe those things also.

A lot of work has been done for a potential BP buyer, more risk removed, more confidence in "real" indications with benefits appearing strong. Seems more a matter of who, when, how much to me also.

Pure speculation, but I would not be surprised at all if there were multiple bids on the table with a range of valuations pending coming FDA/EUDA dispositions to better illuminate the time/expense risks to market. The clinical foundation took a GIANT leap forward with BoM, regardless of the TLD miss slowing it down. 

jmho's though